KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Colgate Palmolive (CL) Gains from Investment Securities (2016 - 2025)

Colgate Palmolive (CL) has 16 years of Gains from Investment Securities data on record, last reported at $9.0 million in Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 156.25% year-over-year to $9.0 million; the TTM value through Dec 2025 reached $14.0 million, up 137.84%, while the annual FY2025 figure was $14.0 million, 137.84% up from the prior year.
  • Gains from Investment Securities reached $9.0 million in Q4 2025 per CL's latest filing, up from $4.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $25.0 million in Q4 2021 and bottomed at -$18.0 million in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $1.5 million, with a median of $3.0 million recorded in 2023.
  • Peak YoY movement for Gains from Investment Securities: surged 1050.0% in 2023, then crashed 900.0% in 2024.
  • A 5-year view of Gains from Investment Securities shows it stood at $25.0 million in 2021, then tumbled by 116.0% to -$4.0 million in 2022, then skyrocketed by 150.0% to $2.0 million in 2023, then plummeted by 900.0% to -$16.0 million in 2024, then soared by 156.25% to $9.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were $9.0 million in Q4 2025, $4.0 million in Q3 2025, and $3.0 million in Q2 2025.